1. Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial
- Author
-
Jiang, Zefei, primary, Ouyang, Quchang, additional, Sun, Tao, additional, Zhang, Qingyuan, additional, Teng, Yuee, additional, Cui, Jiuwei, additional, Wang, Haibo, additional, Yin, Yongmei, additional, Wang, Xiaojia, additional, Zhou, Xin, additional, Wang, Yongsheng, additional, Sun, Gang, additional, Wang, Jingfen, additional, Zhang, Lili, additional, Yang, Jin, additional, Qian, Jun, additional, Yan, Min, additional, Liu, Xinlan, additional, Yi, Tienan, additional, Cheng, Ying, additional, Li, Man, additional, Zang, Aimin, additional, Wang, Shusen, additional, Wang, Chuan, additional, Wu, Xinhong, additional, Cheng, Jing, additional, Li, Hui, additional, Lin, Ying, additional, Geng, Cuizhi, additional, Gu, Kangsheng, additional, Xie, Chunwei, additional, Xiong, Huihua, additional, Wu, Xiaohong, additional, Yang, Junlan, additional, Li, Qingshan, additional, Chen, Yiding, additional, Li, Fanfan, additional, Zhang, Anqin, additional, Zhang, Yongqiang, additional, Wu, Yudong, additional, Nie, Jianyun, additional, Liu, Qiang, additional, Wang, Kun, additional, Mo, Xueli, additional, Chen, Lilin, additional, Pan, Yueyin, additional, Fu, Peifen, additional, Zhang, Helong, additional, Pang, Danmei, additional, Sheng, Yuan, additional, Han, Yunwei, additional, Wang, Hongxia, additional, Cang, Shundong, additional, Luo, Xianming, additional, Yu, Wenbo, additional, Deng, Rong, additional, Yang, Chaoqiang, additional, and Keegan, Patricia, additional
- Published
- 2024
- Full Text
- View/download PDF